Vividion Therapeutics is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets.
Vividion Therapeutics was acquired by Bayer on August 5, 2021. Forge no longer actively tracks this company.
What is Vividion Therapeutics's ticker symbol?
Vividion Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
What is Vividion Therapeutics's stock price?
The stock price for Vividion Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
Vividion Therapeutics Funding Rounds and IPO Valuation
Price per Share
Series A-2 and A-3
Based on primary financings
Learn more about Vividion Therapeutics
What is Vividion Therapeutics funding to date?
Vividion Therapeutics has raised $267.82MM with the following series: $11.32MM for Series A, $118.29MM for Series A-2 and A-3, $304.43MM for Series B, $600.09MM for Series C
When was Vividion Therapeutics founded?
Vividion Therapeutics was founded in 2017.
Can you invest in Vividion Therapeutics?
Vividion Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Vividion Therapeutics share pre-IPO?
If you own Vividion Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.
Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.
Is Vividion Therapeutics a publicly traded company?
Vividion Therapeutics is a private company and not publicly traded.
If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.
Other companies like Vividion Therapeutics in the Healthcare sector